VerifiedEvidence: highv1.0.0

Mapping Algorithm

A statistical model predicting a health utility value from responses on a non-preference-based instrument, used when a preference-based measure was not collected.

Last reviewedDarrin Baines IP Ltd

Concept Architecture

Concept

Theoretically, Mapping Algorithm is a statistical prediction model used to estimate health state utility values from non-preference-based health outcome measures when direct utility data are unavailable. It is founded on regression modelling and statistical prediction theory and exists to enable quality-adjusted life year estimation from clinical studies that did not collect preference-based measures. Mapping algorithms are widely used in health economic evaluation when preference-based utility instruments such as EQ-5D were not administered.

Mathematically, mapping algorithms have no universally recognised canonical mathematical formula. They are represented by fitted statistical models that predict utility values from one or more explanatory variables derived from disease-specific or generic health measures. The mathematical framework estimates the expected utility conditional on observed patient characteristics or questionnaire scores.

In practice, mapping algorithms are developed using datasets containing both the source instrument and a preference-based utility measure. Regression coefficients are estimated using recognised statistical methods, internally and externally validated, and subsequently applied to new datasets to predict utility values for economic evaluation. Good practice recommends transparent reporting of predictive accuracy, model performance and uncertainty.


Purpose

Used to estimate preference-based health utility values from non-preference-based health outcome measures when direct utility data are unavailable, thereby supporting cost-utility analysis and health technology assessment.


Mathematical Formulae

Primary Formula

There is no universally recognised canonical mathematical formula.

Supporting Formulae

U? = ?? + ????? ??X? + �

where:

  • U? = predicted health utility
  • ?? = intercept
  • ?? = estimated regression coefficients
  • X? = predictor variables from the source instrument
  • � = random error

RMSE = �[(1?n)????�(U? ? U??)�]

MAE = (1?n)????�|U? ? U??|

Related Mathematical Methods

  • Ordinary least squares regression
  • Generalised linear models
  • Tobit regression
  • Beta regression
  • Response mapping
  • Cross-validation
  • Root mean squared error (RMSE)
  • Mean absolute error (MAE)

Example

A clinical study collected scores from a disease-specific quality of life questionnaire but did not administer EQ-5D. A published mapping algorithm predicts EQ-5D utility as:

U? = 0.92 ? 0.015(Symptom Score)

For a patient with a symptom score of 18:

U? = 0.92 ? 0.015 ? 18 = 0.650

The predicted utility of 0.650 is then used to estimate QALYs in a cost-utility analysis.


Excel Implementation

FunctionExample FormulaHealth Economics Application
SUMPRODUCT=SUMPRODUCT(B2:F2,$B$1:$F$1)+$A$1Calculates predicted utility from published regression coefficients.
LINEST=LINEST(Y2:Y201,B2:F201,TRUE,TRUE)Estimates regression coefficients when developing a mapping algorithm.
SQRT=SQRT(AVERAGE((Y2:Y201-Z2:Z201)^2))Calculates RMSE for model validation.
ABS=ABS(Y2-Z2)Calculates absolute prediction error for MAE estimation.

VBA (Optional)

Automate the application of published mapping algorithms to patient datasets and generate predicted utility values with model performance statistics.


Sources

  • Wailoo AJ, Hernandez-Alava M, Manca A, et al. Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report. Value in Health. 2017.
  • Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press.
  • NICE. Health Technology Evaluation Manual.
  • Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford University Press.

Library

Publications

2
  • BookFeatured

    Measuring and Valuing Health Benefits for Economic Evaluation — Brazier, Ratcliffe, Salomon & Tsuchiya, 2nd Edition ed., 2017 (Oxford University Press)

    The comprehensive text on the measurement and valuation of health benefits for economic evaluation — defining health, valuation techniques (time trade-off, standard gamble), whose values to use, preference-based measures (EQ-5D, SF-6D), and the construction of QALYs.

  • Guidance

    NICE DSU Technical Support Document 9: The Identification, Review and Synthesis of Health State Utility Values from the Literature — Papaioannou, Brazier & Paisley, TSD 9 ed., 2011 (NICE Decision Support Unit (University of Sheffield))

    Guidance on systematically identifying, reviewing and synthesising health-state utility values (HSUVs) from the published literature for use in cost-utility models.

Frequently Asked Questions (6)

  • What is a mapping algorithm?

    A statistical model predicting a health utility value from responses on a non-preference-based instrument, used when a preference-based measure was not collected.

    Source: Longworth & Rowen 2013

  • Why are mapping algorithms needed?

    A mapping algorithm is needed when a study has measured health with an instrument that does not itself yield utilities, yet a cost-utility analysis requires them. Rather than abandon the data or collect new preference-based responses, an algorithm estimated from a separate sample, where both the non-preference measure and a utility measure were recorded, is used to predict the missing utilities from what was collected. This lets existing trial data feed economic models. Brazier and colleagues (2010) explain the circumstances that make mapping necessary.

    Source: Brazier et al. 2010

  • How is a mapping algorithm developed?

    A mapping algorithm is developed from data in which respondents completed both the non-preference-based instrument and a preference-based measure, allowing the statistical relationship between them to be estimated. A model, usually a regression, is fitted to predict the utility from the non-preference-based scores. This model is then applied to other data where only the non-preference-based instrument was used, generating predicted utilities. Its quality depends on the estimation data and the model.

    Source: Longworth & Rowen 2013

  • When is a mapping algorithm used?

    A mapping algorithm is used when a study, often a clinical trial, collected only a non-preference-based or condition-specific outcome measure, so no utilities are available for cost-utility analysis, but quality-adjusted life years are needed. Rather than abandon the analysis, the algorithm estimates the utilities from the data collected. It is a second-best solution, appropriate where a preference-based measure was not administered, and its use is reported given the uncertainty it introduces.

    Source: Longworth & Rowen 2013

  • What are the limitations of a mapping algorithm?

    A mapping algorithm predicts utilities rather than measuring them, so it introduces error and uncertainty, and it can only reflect the aspects of health shared by the two instruments, missing what the preference-based measure would capture but the source instrument does not. Predictions tend to be less accurate at the extremes of health, and the algorithm is specific to the populations and instruments from which it was derived. Direct measurement with a preference-based instrument is preferred.

    Source: Longworth & Rowen 2013

  • How reliable are utilities from mapping?

    Utilities from mapping are estimates, generally less reliable than those measured directly with a preference-based instrument, and their accuracy depends on how well the source instrument's scores predict utility and on the quality of the estimation data. Mapping often performs poorly at the healthy and severe extremes and can understate variation. The added uncertainty is carried into the economic evaluation, so mapped utilities are used with caution and their limitations acknowledged where direct measurement was not possible.

    Source: Longworth & Rowen 2013

Trust Record

Verified by Dr Darrin Baines

British health economist

Professional identity: darrinbaines.org

Verification date: 1 Sep 2025

Content version: 1.0.0

Canonical Identity

Term code
HE-EE-HU-046

Stable URI · Machine-readable · Resolvable · CC BY 4.0